Contineum Therapeutics, Inc. Class A Common Stock - CTNM
About Gravity Analytica
Recent News
- 02.03.2026 - LPA1 Expression in CNS Fibroblasts During Multiple Sclerosis
- 01.28.2026 - Exploring the Effects of SARM1 Inhibition in Preventing Neurodegeneration in Human and Rodent Neuropathic Pain Models
Recent Filings
- 01.30.2026 - 4 Statement of changes in beneficial ownership of securities
- 01.30.2026 - 4 Statement of changes in beneficial ownership of securities
- 01.30.2026 - 4 Statement of changes in beneficial ownership of securities
- 01.30.2026 - 4 Statement of changes in beneficial ownership of securities
- 01.30.2026 - 4 Statement of changes in beneficial ownership of securities
- 01.29.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
- 01.26.2026 - 8-K Current report
- 01.06.2026 - 4 Statement of changes in beneficial ownership of securities
- 01.05.2026 - 144 Report of proposed sale of securities
- 12.30.2025 - 4 Statement of changes in beneficial ownership of securities